Answer
Co-amilofruse’s furosemide component must not be given during pregnancy unless there are compelling medical reasons, and treatment requires monitoring of foetal growth; its amiloride component is not recommended during pregnancy because its safety has not been established.
Sources for this answer
- Co-Amilofruse 5mg/40mg TabletsWockhardt UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked